Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Vitamin B3
100%
Traumatic Brain Injury
100%
Middle-aged
57%
Middle-aged Rats
42%
Aged Rats
42%
Cortical Contusion Injury
42%
Clinical Trials
28%
Disability
28%
Emotional Impairment
28%
Preclinical Evaluation
28%
Sensory-motor Impairment
28%
Mild Traumatic Brain Injury (mTBI)
28%
Healthcare Costs
28%
Cognitive Impairment
28%
Staggering
28%
Traumatic Brain Injury Patients
14%
Older Subjects
14%
Rodent Population
14%
Dosing Regimen
14%
NAD+ Metabolism
14%
Military Actions
14%
General Public
14%
Phase II Trial
14%
Nicotinamide
14%
Rodents
14%
Progesterone
14%
Behavioral Outcomes
14%
Public Health Emergency
14%
Neurodegeneration
14%
Cognitive Function
14%
Dose-response Study
14%
Confounding
14%
Clinical Setting
14%
Specific Aims
14%
Potential Therapy
14%
Aging Population
14%
Pathophysiological Changes
14%
Mechanism Study
14%
Treatment Window
14%
Sensorimotor Function
14%
Edema Formation
14%
Treatment Options
14%
Fluid Percussion Injury
14%
Public Health Risk
14%
Preclinical Assessment
14%
Novel Therapies
14%
Pharmacological Treatment
14%
Reactive Gliosis
14%
Young Rats
14%
Clinically Significant
14%
Neuroscience
Traumatic Brain Injury
100%
Nicotinamide
100%
Neurotrauma
100%
Neurodegeneration
10%
Progesterone
10%
Gliosis
10%
Metabolic Pathway
10%
Cognitive Function
10%
Drug Therapy
10%